Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
A single invitation for a prostate-specific antigen (PSA) screening test results in a small but significant reduction in prostate cancer deaths, but also leads to overdiagnosis and missed early ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...
This is a large-scale, population-based, observational study of two screening strategies: annual PSA screening and no screening. We used data from 537,599 US Medicare (2001-2008) beneficiaries age ...
SAN FRANCISCO—Offering PSA testing for free is associated with a reduction in prostate cancer mortality, according to an Austrian study. The study, presented at the American Urological Association ...
A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has demonstrated that ...
Hosted on MSN
Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for ...
About The Study: A single invitation for prostate-specific antigen (PSA) screening compared with standard practice without routine screening reduced prostate cancer deaths at a median follow-up of 15 ...
Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results